Clinical trial
Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects
NCT00434187 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00434187 |
|---|---|
| Title | Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects |
| Official title | An Ascending Multiple Dose Study of the Safety, Tolerability and Pharmacokinetics of ERB-041 Administered Orally to Healthy, Female Japanese Subjects |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | ERB-041 |
| Enrollment | 24 |
| Start date | Aug 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Feb 13, 2007 |
| Last update posted | Jul 10, 2009 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: